» Publications

SCI-SSCI or SCI Expanded Articles

.A. GÖKYER, A. KÜÇÜKARDA, O. KÖSTEK, B. M. HACIOGLU, S. UZUNOGLU, O. KULA, N. KURT, S. ÜSTÜNDAG, B. ERDOGAN, I. ÇIÇIN, Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study, International Journal of Clinical Oncology, vol. 25, no. 10, pp. 1757-1762, 10, 2020.

.B. M. HACIOGLU, O. KÖSTEK, S. KARABULUT, D. TASTEKIN, S. G. SEZGIN, C. ALANDAG, B. AKAGÜNDÜZ, I. BILGETEKIN, B. CANER, B. A. SAHIN, B. YILDIZ, F. KÖSE, A. M. KAPLAN, A. GÜLMEZ, E. DOGAN, C. D. GÜVEN, M. GÜRBÜZ, Y. ERGÜN, M. KARAAGAÇ, G. A. DEMIRAY, S. TÜRKER, T. SAKALAR, Ö. ÖZKUL, T. T. AKIN, S. SAHIN, S. KILIÇKAP, A. BILICI, B. ERDOGAN, I. ÇIÇIN, Efficacy of Regorafenib in the Second-and Third-line Settingfor Patients with Advanced Hepatocellular Carcinoma: A RealLife Data of Multicenter Study from Turkey, Journal of Balkan Union of Oncology, vol. 25, no. 4, pp. 1897-1903, 7, 2020.

.O. KÖSTEK, C. N. DEMIRCAN, A. GÖKYER, A. KÜÇÜKARDA, S. B. SUNAL, B. M. HACIOGLU, H. ESLAME, S. SOLAK, E. YILMAZ, S. UZUNOGLU, N. TUNÇBILEK, I. ÇIÇIN, B. ERDOGAN, Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer, Clinical and Translational Oncology, vol. 21, no. 11, pp. 1510-1517, 3, 2019.

.B. M. HACIOGLU, O. KÖSTEK, N. KURT, A. KÜÇÜKARDA, A. GÖKYER, E. F. USTABASIOGLU, F. KARATAS, N. TUNÇBILEK, S. UZUNOGLU, A. BILICI, I. ÇIÇIN, B. ERDOGAN, Comparison of skeletal muscle mass loss in patients withmetastatic colorectal cancer treated with regorafenib orTAS-102, Journal of BUON, vol. 24, no. 5, pp. 2198-2204, 10, 2019.

.O. KÖSTEK, E. YiLMAZ, B. M. HACIOGLU, C. N. DEMIRCAN, A. GÖKYER, S. UZUNOGLU, N. TUNÇBILEK, I. ÇIÇIN, B. ERDOGAN, Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 83, no. 4, pp. 735-742, 4, 2019.

.O. KÖSTEK, B. M. HACIOGLU, A. SAKIN, T. DEMIR, M. SARI, Ö. ÖZKUL, M. ARAZ, F. A. DOGAN, C. N. DEMIRCAN, S. UZUNOGLU, I. ÇIÇIN, B. ERDOGAN, Regorafenib or rechallenge chemotherapy: Which is more effective in the third-line treatment of metastatic colorectal cancer?, CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 83, no. 1, pp. 115-122, 1, 2019.

.O. KÖSTEK, Y. BOZKAYA, B. M. HACIOGLU, N. Ö. YiLDiRiM, E. YiLMAZ, C. N. DEMIRCAN, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, N. ZENGIN, Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?, Archives of Iranian Medicine, vol. 22, no. 5, pp. 236-241, 5, 2019.

.A. GÖKYER, A. KÜÇÜKARDA, O. KÖSTEK, B. M. HACIOGLU, S. B. SUNAL, C. N. DEMIRCAN, S. UZUNOGLU, S. SOLAK, K. ISSEVER, I. ÇIÇIN, B. ERDOGAN, Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib, Clinical and Translational Oncology, vol. 21, no. 11, pp. 1518-1523, 3, 2019.

.Ö. EROL, S. ÜNSAR, L. YACAN, M. PELIN, S. KURT, B. ERDOGAN, Pain experiences of patients with advanced cancer: A qualitative descriptive study., European Journal of Oncology Nursing, no. 33, pp. 28-34, 4, 2018.

.O. KÖSTEK, E. YILMAZ, H. B. MUHAMMET, B. ERDOGAN, H. KODAZ, T. E. BEKMEZ, I. HACIBEKIROGLU, S. UZUNOGLU, N. TUNCBILEK, I. ÇIÇIN, Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma, Journal of BUON, 6, 2018.

.B. H. MUHAMMET, O. KÖSTEK, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis., Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol. 22, no. 3, pp. 586-591, 1, 2017.

.H. KODAZ, I. HACIBEKIROGLU, E. TÜRKMEN, B. ERDOGAN, Ç. ELPEN, S. UZUNOGLU, I. ÇIÇIN, Increased dose single agent gemcitabine in platinum taxane resistant metastatic ovarian cancer, Tumori Journal, vol. 101, no. 1, pp. 36-40, 2, 2015.

.H. KODAZ, B. ERDOGAN, I. HACIBEKIROGLU, E. TÜRKMEN, H. GÜRKAN, D. ALBAYRAK, E. TASTEKIN, S. UZUNOGLU, I. ÇIÇIN, Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancer, Medical Oncology, vol. 32, no. 1, 1, 2015.

.I. HACIBEKIROGLU, H. KODAZ, B. ERDOGAN, E. TÜRKMEN, A. ESENKAYA, S. UZUNOGLU, I. ÇIÇIN, Comparative Analysis of the Efficacy and Safety of Oxaliplatin Plus 5 Fluorouracil Leucovorin Modified FOLFOX6 with Advanced Gastric Cancer Patients having a Good or Poor Performance Status, Asian Pacific journal of cancer prevention : APJCP, vol. 16, no. 6, pp. 2355-9, 4, 2015.

.B. ERDOGAN, I. ÇIÇIN, Denosumab a Monoclonal Antibody not a Radionuclide, Asian Pacific journal of cancer prevention : APJCP, vol. 16, no. 5, pp. 2103-, 3, 2015.

.I. HACIBEKIROGLU, H. KODAZ, B. ERDOGAN, E. TÜRKMEN, M. ÖZÇELIK, A. ESENKAYA, M. H. SAYGI, S. UZUNOGLU, I. ÇIÇIN, Erratum to Single agent bevacizumab is an effective treatment in recurrent glioblastoma, Medical Oncology, vol. 32, no. 4, 4, 2015.

.T. ESMA, B. ERDOGAN, H. KODAZ, S. UZUNOGLU, A Small Cell Carcinoma in the Testis Associated with Testicular Teratoma, Balkan Medical Journal, vol. 31, no. 2, pp. 191-192, -TÜRKIYE, 6, 2014.

.I. ÇIÇIN, B. ERDOGAN, E. GÜLSEN, S. UZUNOGLU, N. SÜT, E. TÜRKMEN, H. KODAZ, S. ÜSTÜNDAG, Incidence of contrast induced nephropathy in hospitalised patients with cancer, European Radiology, vol. 24, no. 1, pp. 184-190, 1, 2014.

.S. UZUNOGLU, R. COSAR, I. ÇIÇIN, K. IBIS, E. BENLIER, E. DEMIRALAY, B. ERDOGAN, H. KANDULU, A. ÖZEN, S. ALTANER, Carnitine or dimethyl sulfoxide or both for the treatment of anthracycline extravasation in rats, Journal of Plastic Surgery and Hand Surgery, vol. 47, no. 5, pp. 339-343, 10, 2013.

.V. BERK, A. M. KAPLAN, Ö. TONYALI, S. BÜYÜKBERBER, O. BALAKAN, M. ÖZKAN, U. DEMIRCI, T. T. ÖZTÜRK, A. BILICI, D. TASTEKIN, N. ÖZDEMIR, Ü. O. ÜNAL, U. OFLAZOGLU, E. TÜRKMEN, B. ERDOGAN, Ü. ÜYETÜRK, B. ÖKSÜZOGLU, H. C. YESIL, N. YASAR, M. GÜMÜS, Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma A Retrospective Study by the Anatolian Society of Medical Oncology, Asian Pacific Journal of Cancer Prevention, vol. 14, no. 12, pp. 7367-7369, 12, 2013.

.D. DUMAN, R. DEMIRTUNÇ, B. ERDOGAN, G. S. MANGA, B. KARADAG, Dialysis induced hypotension is associated with impaired aortic elasticity in patients undergoing chronic hemodialysis, Blood Pressure Monitoring, vol. 13, no. 2, pp. 73-78, 1, 2008.

International Articles

.A. KÜÇÜKARDA, A. GÖKYER, I. GÖKMEN, O. KÖSTEK, B. M. HACIOGLU, S. UZUNOGLU, B. ERDOGAN, I. ÇIÇIN, Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis, Journal of oncological sciences, vol. 6, no. 3, pp. 133-140, 12, 2020.

.A. GÖKYER, A. KÜÇÜKARDA, O. KÖSTEK, B. M. HACIOGLU, K. ISSEVER, T. ÖZLER, G. ÇEVIK, S. UZUNOGLU, B. ERDOGAN, I. ÇIÇIN, Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience, Journal of oncological sciences, vol. 6, no. 3, pp. 141-46, 12, 2020.

.Ü. KORKMAZ, B. M. HACIOGLU, O. KÖSTEK, N. SÜT, H. KODAZ, B. ERDOGAN, F. ÜSTÜN, M. SAYNAK, E. TASTEKIN, I. ÇIÇIN, G. ALTUN, The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas, Polish Journal of Radiology, vol. 85, no. 1, pp. 254-260, 5, 2020.

.C. F. KORUCU, E. SENYIGIT, O. KÖSTEK, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, A retrospective study on potential drug interactions: A single center experience, Journal of Oncological Sciences, vol. 4, no. 2, pp. 80-84, 8, 2018.

.B. ERDOGAN, O. KÖSTEK, B. M. HACIOGLU, Enzalutamide and cancer, Eurasian Journal of Medicine and Oncology, vol. 2, no. 3, pp. 121-129, 5, 2018.

.Y. ÖNAL, O. KÖSTEK, B. M. HACIOGLU, B. ERDOGAN, H. KODAZ, T. E. BEKMEZ, I. HACIBEKIROGLU, S. UZUNOGLU, I. ÇIÇIN, Assessment of prognostic factors in epithelial ovarian cancer, Eurasian Journal of Medicine and Oncology, 1, 2017.

.H. KODAZ, O. KÖSTEK, B. M. HACIOGLU, B. ERDOGAN, E. Ç. KODAZ, I. HACIBEKIROGLU, E. TÜRKMEN, S. UZUNOGLU, I. ÇIÇIN, Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer, Eurasian Journal of Medicine and Oncology, 1, 2017.

.A. GÖKYER, O. KÖSTEK, B. M. HACIOGLU, B. ERDOGAN, H. KODAZ, E. TÜRKMEN, I. HACIBEKIROGLU, S. UZUNOGLU, I. ÇIÇIN, Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience, Northern Clinics of Istanbul, vol. 4, no. 1, pp. 43-41, 1, 2017.

.B. ERDOGAN, Z. E. ÖZTÜRK, H. SAVLI, The association between corrected QT dispersion and iron parameters in hemodialysis diseases, Eurasian Journal of Medicine and Oncology, 1, 2017.

.H. KODAZ, I. HACIBEKIROGLU, B. ERDOGAN, E. TÜRKMEN, H. TOZKIR, D. ALBAYRAK, S. UZUNOGLU, I. ÇIÇIN, Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors, Molecular and Clinical Oncology, vol. 3, no. 1, pp. 179-184, 10, 2014.

International Conference Proceedings

.E. M. ÖZEKIN, O. KÖSTEK, B. ERDOGAN, THE ASSOCIATION BETWEEN POST-PROGRESSION SURVIVAL AND CLINICAL CHARACTERISTICS OF THE PATIENTS WITH METASTATIC COLORECTAL CANCER, 9. INTERNATIONAL GASTROINTESTINAL CANCER CONFERENCE.

International Books and Book Chapters

.B. ERDOGAN, I. ÇIÇIN, Breast DiseaseManagement and Therapies, Uluslararasi, Bölüm: Bone-Directed Therapy and Breast Cancer: Bisphosphonates, Monoclonal Antibodies, and Radionuclides, Basim Türü: Basili+Elektronik , ISBN978-3-030-16792-9, springer, 20192. Basim.

National Articles

.C. N. DEMIRCAN, O. KÖSTEK, A. GÖKYER, A. KÜÇÜKARDA, B. M. HACIOGLU, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases, Journal of Surgery and Medicine, 12, 2019.

National Conference Proceedings

.M. P. SAIP, S. KESKIN, Y. KEMAL, S. MENEKSE, D. ÇABUK, Ö. TANRIVERDI, Y. ÜRÜN, E. NAYIR, S. CIHAN, M. KOÇAR, B. CIVELEK, S. ERGEN, M. UYSAL, U. H. BOZBEY, M. GÜNALDI, N. AVCI, B. ERDOGAN, B. ÇAKAR, B. U. OYAN, T. F. KÖS, D. TURAL, H. KARACA, S. TURHAL, C. BILIR, O. SENCAN, S. SAGLAM, Türkiye de Geriatrik Onkoloji Hastalarinin Poliklinik Basvuru Oranlari ve Klinik Özellikleri Çok Merkezli Çalisma, 21. Ulusal Kanser Kongresi, -TÜRKIYE.

.B. ERDOGAN, H. KODAZ, S. KARABULUT, H. TOZKIR, Ö. TANRIVERDI, D. ÇABUK, E. TÜRKMEN, I. HACIBEKIROGLU, S. UZUNOGLU, I. ÇIÇIN, Aktif Sigara Içiciligi EGFR Mutant Akciger Adenokanseri Hastalarinda Kötü Bir Prognostik Faktördür, 21. Ulusal Kanser Kongresi, -TÜRKIYE.

.E. TÜRKMEN, H. KODAZ, I. HACIBEKIROGLU, B. ERDOGAN, Ö. SARI, Ayak parmagi cilt metastazli akciger adenokarsinom olgusu, 5. Türk Tibbi Onkoloji Kongresi, -TÜRKIYE.

.S. UZUNOGLU, E. TÜRKMEN, I. HACIBEKIROGLU, H. KODAZ, B. ERDOGAN, Nazofarinks kanseri tedavisi sonrasi gelisen wegener granülomatozisi ile uyumlu vaskülit olgusu, 5. Türk Tibbi Onkoloji Kongresi, -TÜRKIYE.

.B. SAHIP, E. TÜRKMEN, I. HACIBEKIROGLU, H. KODAZ, B. ERDOGAN, Meme parankimi metastazli koroid malign melanom olgusu, 5. Türk Tibbi Onkoloji Kongresi, -TÜRKIYE.

.H. KODAZ, I. HACIBEKIROGLU, E. TÜRKMEN, Ç. K. ELPEN, B. ERDOGAN, S. M. UYANIK, Endometrium kanseri ve otoimmun paraneoplastik trombositopeni, 5. Türk Tibbi Onkoloji Kongresi, -TÜRKIYE.

.B. ERDOGAN, Altyapisi yetersiz hastanelerde tibbI onkolog olmak, 5. Türk Tibbi Onkoloji Kongresi, -TÜRKIYE.

.S. UZUNOGLU, H. KODAZ, E. TÜRKMEN, B. ERDOGAN, I. ÇIÇIN, V. Ç. YÜRÜT, Dile Metastaz Yapan Renal Hücreli Karsinom Vakasi, 20. Ulusal Kanser Kongresi, -TÜRKIYE.

.E. TÜRKMEN, B. ERDOGAN, S. UZUNOGLU, H. KODAZ, I. ÇIÇIN, Kanser Hastalarinda Kontrastli Bilgisayarli Tomografi Çekimi Sonrasi Kontrast Madde Nefropatisi Gelisme Riski Ve Prediktif Faktörler çalismasi Final Sonuçlari, 20. Ulusal Kanser Kongresi, -TÜRKIYE.

Other

.B. M. HACIOGLU, B. ERDOGAN, I. ÇIÇIN, GEBELIKTE SARKOM TEDAVISI, Ulusal, Bölüm: GEBELIK VE SARKOMLAR, Basim Türü: Basili, pp. 195-207, TÜRKIYE-, ISBN978-975-277-675-3, GÜNES TIP KITAPEVI, 20171. Basim.